Cargando…
Mitigation of the replication of SARS-CoV-2 by nitric oxide in vitro
The ongoing SARS-CoV-2 pandemic is a global public health emergency posing a high burden on nations’ health care systems and economies. Despite the great effort put in the development of vaccines and specific treatments, no prophylaxis or effective therapeutics are currently available. Nitric oxide...
Autores principales: | Akaberi, Dario, Krambrich, Janina, Ling, Jiaxin, Luni, Chen, Hedenstierna, Göran, Järhult, Josef D., Lennerstrand, Johan, Lundkvist, Åke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7505071/ https://www.ncbi.nlm.nih.gov/pubmed/33007504 http://dx.doi.org/10.1016/j.redox.2020.101734 |
Ejemplares similares
-
SARS-CoV-2 in hospital indoor environments is predominantly non-infectious
por: Krambrich, Janina, et al.
Publicado: (2021) -
Long-distance airborne dispersal of SARS-CoV-2 in COVID-19 wards
por: Nissen, Karolina, et al.
Publicado: (2020) -
Corrigendum to “Presymptomatic viral shedding and infective ability of SARS-CoV-2; a case report” [Heliyon 7, (2), (February 2021), Article e06328]
por: Nissen, Karolina, et al.
Publicado: (2022) -
Reduced Binding between Omicron B.1.1.529 and the Human ACE2 Receptor in a Surrogate Virus Neutralization Test for SARS-CoV-2
por: Hoffman, Tove, et al.
Publicado: (2023) -
Evaluation of a COVID-19 IgM and IgG rapid test; an efficient tool for assessment of past exposure to SARS-CoV-2
por: Hoffman, Tove, et al.
Publicado: (2020)